Guangting Zeng & Yuchi Zhou. (2023). Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection. Elsevier.
Chicago Style (17th ed.) CitationGuangting Zeng and Yuchi Zhou. Pharmacotherapy and Pulmonary Fibrosis Risk After SARS-CoV-2 Infection. Elsevier, 2023.
MLA (9th ed.) CitationGuangting Zeng and Yuchi Zhou. Pharmacotherapy and Pulmonary Fibrosis Risk After SARS-CoV-2 Infection. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.